Accelerator Corp Company Profile

15:18 EDT 22nd September 2018 | BioPortfolio

VieVax Corp. is focused on commercializing a novel approach to vaccine development that is designed to overcome the limitations of existing vaccine technologies. These technologies, largely unchanged and unimproved for the past half-century, have consistently fallen short in addressing a number of critical issues, including: the spread of serious emerging infectious diseases, the emergence of treatment-resistant strains of infectious pathogens, robust and reliable manufacturing, the growing threat of bioterrorism employing infectious pathogens, and, a failure to evelop vaccines against infectious agents such as HIV.


1616 Eastlake Ave. E.
United States of America


Phone: 206.957.7300
Fax: 206.957.7399

News Articles [223 Associated News Articles listed on BioPortfolio]

6 startups enter Boston Scientific-funded medtech accelerator

Six medtech startups have been accepted into startup accelerator gener8tor's second gBETA Medtech accelerator, a Boston Scien -More- 

Global Brand Consultancy to Launch STEAM Focused Accelerator Hub at its Leeds HQ

Global brand design consultancy Elmwood, is set to launch its first accelerator programme in June 2018. Elmwood LaunchPod is a unique project bringing creative and technology start-ups together into a...

Largest Startup Class Yet Enters UC Berkeley’s Expanding Accelerator

More than a hundred startup teams are beginning a training and mentoring program this month at the Berkeley SkyDeck Accelerator—the largest group ever accepted to the UC Berkeley program since i...

UK accelerator secures cell and gene therapy production licenses

Autolus, Cell Medica, Adaptimmune and Freeline are some of the companies already working with the accelerator.

Boomtown, COPIC Launch Patient Safety HealthTech Startup Accelerator

Boulder, CO-based startup accelerator Boomtown and COPIC, a medical liability insurance provider recognized for its innovative patient safety and risk management, have announced a multi-year agreement...

Accelerator Life Science Partners launches new company to develop novel therapy for seizure disorders

Accelerator Life Science Partners (Accelerator), a leading life science investment and management firm, today announced that it has launched Proniras Corporation, a company developing tezampanel for t...

XLerateHealth Accelerator Unveils Its Sixth Class of 10 Digital Health Startups

XLerateHealth, a Louisville-based healthcare accelerator, today announced it has selected ten companies to participate in their sixth cohort of companies. The accelerator’s 12-week intensive program...

AbbVie and Rice University Establish K.C. Nicolaou Research Accelerator to Advance Therapies in Oncology

NORTH CHICAGO, Ill. and HOUSTON, April 30, 2018 /PRNewswire/ — AbbVie, a research-based global biopharmaceutical company, and Rice University today announced they have entered into a joint resea...

PubMed Articles [52 Associated PubMed Articles listed on BioPortfolio]

A photon source model based on particle transport in a parameterized accelerator structure for Monte Carlo dose calculations.

An accurate source model of a medical linear accelerator is essential for Monte Carlo (MC) dose calculations. This study aims to propose an analytical photon source model based on particle transport i...

An ultrasensitive electrochemiluminescence biosensor for detection of MicroRNA by in-situ electrochemically generated copper nanoclusters as luminophore and TiO as coreaction accelerator.

Herein, we constructed an ultrasensitive electrochemiluminescence (ECL) biosensor for detecting microRNA-21 (miR-21) based on in-situ generation of copper nanoclusters (Cu NCs) as luminophore and tita...

Design considerations for a Pulse Line Ion Accelerator (PLIA)-based PET isotope generator.

Positron emission tomography (PET) imaging remains limited by the cost associated with on-site production of short half-life, positron emitting isotopes. In this work, we examine the use of a pulse li...

First Six Dimensional Phase Space Measurement of an Accelerator Beam.

This Letter presents the first complete six dimensional phase space measurement of a beam in an accelerator. The measurement was made on the Spallation Neutron Source Beam Test Facility. The data reve...

Towards femtosecond-level intrinsic laser synchronization at fourth generation light sources.

In this Letter, the proof of principle for a scheme providing intrinsic femtosecond-level synchronization between an external laser system and fourth generation light sources is presented. The scheme ...

Clinical Trials [20 Associated Clinical Trials listed on BioPortfolio]

First-In Man (FIM) Study MR-Linac

Investigational device is the Magnetic resonance imager linear accelerator. Five (5) patients with bone metastases will be treated with palliative intention in this study. The goal is to c...

Evaluation of Capsulotomy by Linear Accelerator Radiosurgery in Severe and Refractory Obsessive-compulsive Disorder

The aim of this study is to evaluate, through a pilot study with about ten cases, if bilateral ventral capsulotomy by linear accelerator enable modification of obsessive-compulsive symptom...

Stereotactic Body Radio Therapy (SBRT) for Early-Stage Non Small Cell Lung Cancer (NSCLC)

The purpose of this study is to evaluate local disease control after 2 years in patients with non-metastatic, non-operated non-small-cell lung cancer treated by radiotherapy. Eligible pat...

Autoimmune Diabetes Accelerator Prevention Trial

The autoimmune diabetes ACCELERATOR PREVENTION TRIAL (adAPT) is based on the accelerator hypothesis. The trial is designed to establish whether metformin, an oral hypoglycaemic agent that ...

Molecular-Guided Surgery for Pancreatic and GI Neuroendocrine Cancers

The purpose of this study is to see if we can use 68Gallium- positron emission tomography and computer tomography (PET/CT) scans using NETSPOT® (Advanced Accelerator Applications USA, Inc...

Companies [100 Associated Companies listed on BioPortfolio]

Accelerator Life Science Partners

Accelerator Life Science Partners catalyzes the development and commercialization of breakthrough biotechnology innovations. Accelerator is a trusted partner that provides the com...


Cydan is an orphan drug accelerator that identifies and de-risks assets with therapeutic and commercial potential. The accelerator’s model evaluates programs for treating rar...

Triphase Accelerator Corporation

Triphase Accelerator is a private drug development company with a primary focus on oncology and with operations in Toronto and San Diego. Triphase Accelerator is dedicated to adva...

SKTA Innopartners

SKTA Innovation Accelerator is a different kind of accelerator based in Silicon Valley. We seed core technology startups by matching entrepreneurs with Strategic Partners committe...

Cydan, LLC

Cydan is an orphan drug accelerator that identifies and de-risks assets with therapeutic and commercial potential. The accelerator’s model evaluates programs for treating rar...

More Information about "Accelerator Corp" on BioPortfolio

We have published hundreds of Accelerator Corp news stories on BioPortfolio along with dozens of Accelerator Corp Clinical Trials and PubMed Articles about Accelerator Corp for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Accelerator Corp Companies in our database. You can also find out about relevant Accelerator Corp Drugs and Medications on this site too.

Quick Search


Relevant Topics

A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

Corporate Database Quicklinks

Searches Linking to this Company Record